Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/171992
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAso Pérez, Ester-
dc.contributor.authorMartinsson, Isak-
dc.contributor.authorAppelhans, Dietmar-
dc.contributor.authorEffenberg, Christiane-
dc.contributor.authorBenseny Cases, Núria-
dc.contributor.authorCladera, Josep-
dc.contributor.authorGouras, Gunnar-
dc.contributor.authorFerrer, Isidro (Ferrer Abizanda)-
dc.contributor.authorKlementieva, Oxana-
dc.date.accessioned2020-11-12T09:47:39Z-
dc.date.available2020-11-12T09:47:39Z-
dc.date.issued2019-04-01-
dc.identifier.issn1743-5889-
dc.identifier.urihttp://hdl.handle.net/2445/171992-
dc.description.abstractPoly(propylene imine) dendrimers have been shown to be promising 3-dimensional polymers for the use in the pharmaceutical andbiomedical applications. Our aims of this study were first, to synthesize a novel type of dendrimer with poly(propylene imine) core andmaltose-histidine shell (G4HisMal) assessing if maltose-histidine shell can improve the biocompatibility and the ability to cross the blood-brain barrier, and second, to investigate the potential of G4HisMal to protect Alzheimer disease transgenic mice from memory impairment.Our data demonstrate that G4HisMal has significantly improved biocompatibility and ability to cross the blood-brain barrier in vivo.Therefore, we suggest that a maltose-histidine shell can be used to improve biocompatibility and ability to cross the blood-brain barrier ofdendrimers. Moreover, G4HisMal demonstrated properties for synapse and memory protection when administered to Alzheimer diseasetransgenic mice. Therefore, G4HisMal can be considered as a promising drug candidate to prevent Alzheimer disease via synapse protection1-
dc.format.extent12 p.-
dc.format.mimetypeapplication/pdf-
dc.language.isoeng-
dc.publisherFuture Medicine-
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1016/j.nano.2019.01.010-
dc.relation.ispartofNanomedicine, 2019, vol. 17, p. 198-209-
dc.relation.urihttps://doi.org/10.1016/j.nano.2019.01.010-
dc.rightsCC-BY (c) Future Medicine, 2019-
dc.rights.urihttp://creativecommons.org/licenses/by-cc-by/3.0/-
dc.sourceArticles publicats en revistes (Patologia i Terapèutica Experimental)-
dc.subject.classificationTrastorns de la memòria-
dc.subject.classificationNeurologia-
dc.subject.classificationPolipropilè-
dc.subject.otherMemory disorders-
dc.subject.otherNeurology-
dc.subject.otherPolypropylene-
dc.titlePoly(propylene imine) dendrimers with histidine-maltose shell as novel type of nanoparticles for synapse and memory protection-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.identifier.idgrec686629-
dc.date.updated2020-11-12T09:47:39Z-
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess-
dc.identifier.pmid30708052-
Appears in Collections:Articles publicats en revistes (Patologia i Terapèutica Experimental)
Articles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))

Files in This Item:
File Description SizeFormat 
686629.pdf3.41 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons